NLRP3 and glaucoma: The key role of NLRP3 inflammasome activation in glaucoma has been highlighted, leading to increased pro-inflammatory cytokine release and creating a chronic inflammatory environment in the retina, which can exacerbate RGC loss and contribute to neurodegeneration [72, 73].